Form 57.123 Antimicrobial Use and Resistance (AUR): Microbiology Lab

Antimicrobial Use and Resistance (AUR): Microbiology Laboratory Data

Monthly Electronic Upload Specification Tables

These data will be collected in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA).

Page 1 of 2
Table 1. CDA File Descriptors		These data elements will be transmitted with each month’s report.
Variable Name	Description of Variable
orgid	NHSN Facility ID number
location	NHSN location code
month	Denominator month
year	Denominator year
Application OID	Vendor software ID number
SDS validation ID	ID provided by NHSN Team confirming vendor software passed validation
Table 2. Isolate Event Details		These data elements will be transmitted with each month’s report.
Variable Name	Description of Variable				Examples
eventID	Event ID number
specimenDate	Date specimen collected
specimenSource	Specimen Source				Blood, lower respiratory, urine, cerebral spinal fluid, skin, soft tissue, wound, musculoskeletal
isolateID	Isolate identifier
facilityAdmitDate	Date admitted to facility
admitStatus	Was patient admitted to an inpatient location				Y/N
specimenLoc	Location of specimen collection
pathogen	Identified pathogen
PtDOB	Patient date of birth
PtSex	Patient sex
PtID	Patient ID number
PtRace	Patient race
PtEthnicity	Patient ethnicity
Table 2a. List of Eligible Pathogens				This is the list of pathogens that will be accepted into NHSN as part of the antimicrobial resistance reporting. Complete list of accepted pathogens is found in the NHSN IDM Workbook.
Acinetobacter species			Enterococcus species			Serratia marcescens
Candida species			Escherichia coli			Staphylococcus aureus
Citrobacter species			Klebsiella species			Stenotrophomonas maltophilia
Enterobacter species			Morganella morganii			Streptococcus agalactiae
Enterococcus faecalis			Proteus species			Streptococcus pneumoniae
Enterococcus faecium			Pseudomonas aeruginosa			Streptococcus pyogenes
Assurance of Confidentiality:  The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)). Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS H21-8, Atlanta, GA 30333, ATTN:  PRA (0920-0666). CDC 57.123 v10, 13.0

Antimicrobial Use and Resistance (AUR): Microbiology Laboratory Data

Monthly Electronic Upload Specification Tables

Page 2 of 2
Table 3. Antimicrobial Susceptibility Details				These data elements will be transmitted with each month’s report.
Variable Name	Description of Variable							Examples
drug test	Antimicrobial used for susceptibility test
PBP2a-agglutination	PBP2a-agglutination
PCRmec-gene	PCR mec-gene
EtestSign	Etest sign							>, <, =
EtestValue	Etest value
EtestInterp	Interpretation of Etest
MICsign	MIC sign
MICinterp	Interpretation of the MIC test
MICvalue	MIC value
ZoneSign	Zone sign
ZoneInterp	Interpretation of zone test
ZoneValue	Zone value
FinIntrep	Final interpretation result
Table 3a. List of Antimicrobials used for Susceptibility Testing						This is the list of antimicrobials that will be accepted into NHSN as part of the antimicrobial resistance reporting.
Amikacin		Cefotetan			Daptomycin		Meropenem-vaborbactam	Rifampin
Amoxicillin		Cefoxitin			Doxycycline		Micafungin	Streptomycin
Amoxicillin-clavulanic acid		Ceftaroline			Ertapenem		Minocycline	Streptomycin – high level
Amphotericin B		Ceftazidime			Erythromycin		Moxifloxacin	Sulbactam/Durlobactam
Ampicillin		Ceftazidime/Avibactam			Fluconazole		Nitrofurantoin	Tedizolid
Ampicillin-sulbactam		Ceftibuten			Fosfomycin		Oritavancin	Telavancin
Anidulafungin		Ceftolozane/Tazobactam			Gentamicin		Oxacillin	Tetracycline
Azithromycin		Ceftriaxone			Gentamicin – high level		Penicillin G	Trimethoprim-sulfamethoxazole
Aztreonam		Cefuroxime			Imipenem-cilastatin		Penicillin V	Vancomycin
Caspofungin		Ciprofloxacin			Imipenem-relebactam with cilastatin		Piperacillin-tazobactam	Voriconazole
Cefazolin		Clarithromycin			Lefamulin		Plazomicin
Cefepime		Clindamycin			Levofloxacin		Polymyxin B
Cefiderocol		Colistin			Linezolid		Posaconazole
Cefotaxime		Dalbavancin			Meropenem		Rezafungin
Table 4. Denominator Data			These data elements will be transmitted with each month’s report.
Variable Name	Description of Variable
numAdmissions	Number of admissions
numPtDays	Number of inpatient days
numEncounters	Number of outpatient encounters
noAREvent	No AR Events were identified

CDC 57.123 (Back) v10, 13.0